Assessment of the Prevalence of Rheumatic Heart Disease in School Settings in Mayotte and the Acquisition of Ultrasound Sequences Guided by Artificial Intelligence

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age7-12
SponsorCentre Hospitalier Universitaire de la Réunion

About this trial

The prevalence of chronic rheumatic heart disease (RHD) on the island of Mayotte is unknown, but it appears to be high and is responsible for significant morbidity and mortality. Screening for RHD in schools is currently the only strategy for managing the cardiac complications of the disease; however, it requires trained medical personnel-a resource that is lacking in Mayotte, as is the case in many developing countries where the disease is endemic. RHD is a sequela of \*Streptococcus pyogenes\* infection, which can originate from tonsillitis or from impetigo secondary to a scabies infestation.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

In one of 30 fourth-grade classes, selected at random from all fourth-grade classes in the department of Mayotte.

For whom at least one of the two holders of parental authority has provided consent (no later than the day of inclusion and prior to any examination required by the research).

Present on the day of the screening and consenting to two ultrasound examinations, each lasting 5 to 20 minutes.

Disqualifiers

Students under guardianship.

Trial design

Design model

Single group

Treatments tested in this trial

  • Ultrasound performed bycardiologis for diagnosis of rheumatic heart disease

    Device

    The following views will be obtained. These include the standard views used for routine screening, plus additional views to screen for common pediatric conditions: parasternal long-axis, parasternal short-axis (aortic level), parasternal short-axis (mitral level), three-chamber, two-chamber, subcostal four-chamber (to screen for an atrial septal defect), parasternal short-axis (at the base), and suprasternal (to screen for a patent ductus arteriosus).

Treatment groups

900 Participants
are divided into 1 treatment group
Group A: Ultrasound performed bycardiologis for diagnosis of rheumatic heart diseaseExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Prevalence of rheumatic heart disease (RHD) among children in the fourth year of primary school (CM1) in the population of Mayotte, based on the screening criteria proposed by the WHF in 2023.

Prevalence of rheumatic heart disease (RHD) among children in the fourth year of primary school (CM1) in the population of Mayotte, based on the screening criteria proposed by the WHF in 2023.

Time frame
enrollment

Secondary outcomes

Other outcomes

Locations

This trial has no locations.

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: